These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 24502587)
1. Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient. Cho JH; Lee JH; Park GY; Lim JH; Kim JS; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD Ren Fail; 2014 May; 36(4):623-6. PubMed ID: 24502587 [TBL] [Abstract][Full Text] [Related]
2. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis. Rodríguez-Ferrero M; Ampuero J; Anaya F Transplant Proc; 2009; 41(6):2406-8. PubMed ID: 19715934 [TBL] [Abstract][Full Text] [Related]
3. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis. Gossmann J; Scheuermann EH; Porubsky S; Kachel HG; Geiger H; Hauser IA Transpl Int; 2007 Jun; 20(6):558-62. PubMed ID: 17433091 [TBL] [Abstract][Full Text] [Related]
4. Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation. Tsagalis G; Psimenou E; Nakopoulou L; Laggouranis A Artif Organs; 2011 Apr; 35(4):420-5. PubMed ID: 20637013 [TBL] [Abstract][Full Text] [Related]
5. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab. Hristea D; Hadaya K; Marangon N; Buhler L; Villard J; Morel P; Martin PY Transpl Int; 2007 Jan; 20(1):102-5. PubMed ID: 17181660 [TBL] [Abstract][Full Text] [Related]
6. Fatal late-onset Pneumocystis pneumonia after rituximab: administration for posttransplantation recurrence of focal segmental glomerulosclerosis--case report. Dęborska-Materkowska D; Kozińska-Przybył O; Mikaszewska-Sokolewicz M; Durlik M Transplant Proc; 2014 Oct; 46(8):2908-11. PubMed ID: 25380948 [TBL] [Abstract][Full Text] [Related]
7. Successful Treatment of Focal Segmental Glomerulosclerosis Recurrence in a Second Kidney Transplant Patient: A Case Report. Argiolas D; Carta E; Mascia G; Michittu MB; Piredda GB Transplant Proc; 2019; 51(1):223-225. PubMed ID: 30580884 [TBL] [Abstract][Full Text] [Related]
8. Plasmapheresis and immunoadsorption for treatment and prophylaxis of recurrent focal segmental glomerulosclerosis in adult recipients of deceased donor renal grafts. Kandus A; Ponikvar R; Buturović-Ponikvar J; Bren AF; Oblak M; Mlinšek G; Kmetec A; Arnol M Ther Apher Dial; 2013 Aug; 17(4):438-43. PubMed ID: 23931886 [TBL] [Abstract][Full Text] [Related]
9. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports. Fencl F; Simková E; Vondrák K; Janda J; Chadimová M; Stejskal J; Seeman T Transplant Proc; 2007 Dec; 39(10):3488-90. PubMed ID: 18089416 [TBL] [Abstract][Full Text] [Related]
10. Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients. Straatmann C; Kallash M; Killackey M; Iorember F; Aviles D; Bamgbola O; Carson T; Florman S; Vehaskari MV Pediatr Transplant; 2014 Feb; 18(1):29-34. PubMed ID: 24266922 [TBL] [Abstract][Full Text] [Related]
11. Different effects of rituximab on a native kidney and a post-transplant kidney with recurrence of focal segmental glomerulosclerosis. Ino A; Kaori S; Takei T; Nitta K CEN Case Rep; 2020 Aug; 9(3):195-199. PubMed ID: 31997159 [TBL] [Abstract][Full Text] [Related]
12. Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis. Meyer TN; Thaiss F; Stahl RA Transpl Int; 2007 Dec; 20(12):1066-71. PubMed ID: 17887957 [TBL] [Abstract][Full Text] [Related]
13. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report. Kolonko A; Piecha G; Więcek A Transplant Proc; 2016 Nov; 48(9):3092-3094. PubMed ID: 27932154 [TBL] [Abstract][Full Text] [Related]
14. Case report: successful treatment of recurrent focal segmental glomerulosclerosis with a novel rituximab regimen. Stewart ZA; Shetty R; Nair R; Reed AI; Brophy PD Transplant Proc; 2011 Dec; 43(10):3994-6. PubMed ID: 22172885 [TBL] [Abstract][Full Text] [Related]
15. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation. Dello Strologo L; Guzzo I; Laurenzi C; Vivarelli M; Parodi A; Barbano G; Camilla R; Scozzola F; Amore A; Ginevri F; Murer L Transplantation; 2009 Aug; 88(3):417-20. PubMed ID: 19667947 [TBL] [Abstract][Full Text] [Related]
17. Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports. Kamar N; Faguer S; Esposito L; Guitard J; Nogier MB; Durand D; Rostaing L Clin Nephrol; 2007 Apr; 67(4):250-4. PubMed ID: 17474562 [TBL] [Abstract][Full Text] [Related]
18. Pretransplantation combined therapy with plasmapheresis and rituximab in a second living-related kidney transplant pediatric recipient with a very high risk for focal segmental glomerulosclerosis recurrence. Chikamoto H; Hattori M; Kuroda N; Kajiho Y; Matsumura H; Fujii H; Ishizuka K; Hisano M; Akioka Y; Nozu K; Kaito H; Shimizu M Pediatr Transplant; 2012 Nov; 16(7):E286-90. PubMed ID: 22129369 [TBL] [Abstract][Full Text] [Related]
19. Individualized scheme of immunoadsorption for the recurrence of idiopathic focal segmental glomerulosclerosis in the graft: a single center experience. Lionaki S; Vlachopanos G; Georgalis A; Liapis G; Skalioti C; Zavos G; Boletis JN Ren Fail; 2015 Jun; 37(5):777-83. PubMed ID: 25715638 [TBL] [Abstract][Full Text] [Related]